GL1X · GenesisL1 explorer

Research workbench

Minimal human cftr first nucleotide binding domain as a head-to-tail dimer with delta F508

Analyse Minimal human cftr first nucleotide binding domain as a head-to-tail dimer with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2PZF
Type
protein
Length
440 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cystic fibrosis transmembrane conductance regulator
EC
3.6.3.49
UniProt
P13569
Ligands
ATP, MG
Pockets
2 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 34% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACystic fibrosis transmembrane conductance regulator (EC 3.6.3.49)protein22434% helix, 27% strandP13569
BCystic fibrosis transmembrane conductance regulator (EC 3.6.3.49)protein21633% helix, 27% strandP13569

Ligands and binding sites

  • ATP · Adenosine-5'-triphosphate · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111710.780.80126MG, ATP
2840.730.9623empty

Interfaces

1 interface between chains.

  • A–B · 1017 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 2PZF · Minimal human CFTR first nucleotide binding domain as a head-to-tail dimer with delta F508 · the same entry in another collection · chain A against A, TM-score 1.00
  • P13569 · AlphaFold monomer V2.0 prediction for cystic fibrosis transmembrane conductance regulator… · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.